Skip to content
Medical Health Aged Care, Research Development

ANZGOG Announces Keynote Speaker for 2025 Annual Scientific Meeting: A/Professor Carien Creutzberg

Australia New Zealand Gynaecological Oncology Group (ANZGOG) 2 mins read

The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the 2024 ANZGOG Annual Scientific Meeting (ASM), taking place in Canberra from 5-7 March 2025. 

Professor Creutzberg, a distinguished expert in gynaecological cancers from Leiden University Medical Center, Netherlands, has dedicated more than three decades to advancing clinical research and improving treatment outcomes for patients with gynaecological malignancies. As the chief investigator of the internationally recognised PORTEC trials on endometrial cancer, her groundbreaking research has shaped global treatment guidelines and continues to drive advancements in personalised cancer care. 

Her leadership extends beyond research, as a co-founder of the Dutch Gynaecological Oncology Group and the TransPORTEC Consortium, which has significantly enhanced molecular understanding of endometrial cancer. In recognition of her outstanding contributions to the field, Professor Creutzberg was awarded the International Gynecologic Cancer Society (IGCS) Lifetime Achievement Award. 

ANZGOG’s ASM brings together national and international experts in gynaecological medicine, radiation and surgical oncology, pathology, basic scientists, translational and quality of life researchers, study coordinators and nurses, as well as our partners in the pharmaceutical industry. The meeting enables attendees to learn about the latest developments in gynaecological cancer and provides education and capacity-building opportunities amongst members and industry personnel, making it an essential event for anyone involved in gynaecological cancers.   

Don’t miss out on this unique opportunity to hear from one of the world’s leading experts in gynaecological oncology. For more information and to register, visit www.anzgogasm.org.au. #ANZGOG2025ASM - ENDS 


About us:

About ANZGOG: The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is the peak national gynaecological cancer research organisation for Australia and New Zealand. Our mission is to improve outcomes and quality of life for everyone with a lived experience of gynaecological cancer by conducting and promoting clinical trials and multidisciplinary research.​ 


Contact details:

Media Contact:  

Monique Cerreto, ANZGOG Head of Communications & Engagement 

E: [email protected]  P: +61 0416 282 464

Media

More from this category

  • Medical Health Aged Care
  • 12/12/2025
  • 10:11
Cosette Pharmaceuticals, Inc.

Termination of Proposed Acquisition of Mayne Pharma

BRIDGEWATER, N.J.–BUSINESS WIRE– Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on…

  • Contains:
  • Medical Health Aged Care
  • 12/12/2025
  • 08:55
Royal Australian College of GPs

Universal Health Coverage Day: RACGP calls out need for better funding for chronic conditions and preventive care

Specialist GPs have marked International Universal Health Coverage (UHC) Day by joining the World Health Organization in highlighting the devastating impact of health costs. The Royal Australian College of GPs (RACGP) has stressed that a public health system which forces patients with complex or chronic conditions to pay out of pocket for longer consultations can’t claim to offer universal coverage, and urged governments to protect patients from financial hardship. “Health is a human right,” RACGP President Dr Michael Wright said. “Australia recognises the right of everyone to the highest attainable standard of physical and mental health, and our governments are…

  • Contains:
  • Medical Health Aged Care, Women
  • 12/12/2025
  • 01:00
Breast Cancer Trials

Simple blood tests could help tailor treatment for aggressive breast cancer

Key Facts: Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patients Absence of tumour DNA in blood…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.